Description
MODIFICATION P00002 TO DECREASE MULTIPLE LINE ITEM QUANTITIES NOT EXPECTED TO BE NEEDED IN FY22. VARIOUS BLOOD PRODUCTS, ONE YEAR ONLY, POP 10/1/2021-9/30/2022
Base award description: VARIOUS BLOOD PRODUCTS, ONE YEAR ONLY, POP 10/1/2021-9/30/2022
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-10-01+$356,366= $356,366
- Mod P000012021-12-16-$1,273= $355,093
- Mod P000022022-06-23-$277,978= $77,115
- Mod P000032022-11-18-$39,546= $37,569
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-10-01 | +$356,366 | $356,366 | VARIOUS BLOOD PRODUCTS, ONE YEAR ONLY, POP 10/1/2021-9/30/2022 |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-16 | −$1,273 | $355,093 | VARIOUS BLOOD PRODUCTS, ONE YEAR ONLY, POP 10/1/2021-9/30/2022 |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-06-23 | −$277,978 | $77,115 | MODIFICATION P00002 TO DECREASE MULTIPLE LINE ITEM QUANTITIES NOT EXPECTED TO BE NEEDED IN FY22. VARIOUS BLOOD… |
| Mod P00003· FUNDING ONLY ACTION | 2022-11-18 | −$39,546 | $37,569 | MODIFICATION P00002 TO DECREASE MULTIPLE LINE ITEM QUANTITIES NOT EXPECTED TO BE NEEDED IN FY22. VARIOUS BLOOD… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PNAEF6YNHFY4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626D0127 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C25626N0209 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $71,646 | FY2026 |
| 36C25626N0210 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6506 · BLOOD AND BLOOD PRODUCTS | $239,128 | FY2026 |
| 36C24926N0133 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $390,791 | FY2026 |
| 36C25625N0105 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $144,871 | FY2025 |
| 36C24925N0158 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS | $162,074 | FY2025 |
Other recipients under Q508 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24925P0108 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $51,105 | FY2025 |
| 36C24923N0225 | UNIVERSITY OF LOUISVILLE | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $56,742 | FY2023 |
| 36C24923N0031 | UNIVERSITY OF LOUISVILLE | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $117,554 | FY2023 |
| 36C24923N0024 | AMERICAN NATIONAL RED CROSS, THE | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $1,656,004 | FY2023 |
| 36C24922P0007 | VITALANT | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $101,804 | FY2022 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24922P0004_3600_-NONE-_-NONE- · retrieved 2026-09-26.